These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30904727)

  • 21. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blending process modeling and control by multivariate curve resolution.
    Jaumot J; Igne B; Anderson CA; Drennen JK; de Juan A
    Talanta; 2013 Dec; 117():492-504. PubMed ID: 24209372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanoradical-induced degradation in a pharmaceutical blend during high-shear processing.
    Polizzi MA; Singhal D; Colvin J
    Pharm Dev Technol; 2008; 13(6):457-62. PubMed ID: 18720240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
    Karande AD; Heng PW; Liew CV
    Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of particle characteristics to elucidate mix homogeneity in binary powder blends.
    Vachon MG; Chulia D
    Drug Dev Ind Pharm; 1998 Oct; 24(10):961-71. PubMed ID: 9876551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a micro dosing system for fine powder using a vibrating capillary. Part 1: the investigation of factors influencing on the dosing performance.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):34-41. PubMed ID: 22595639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
    Thalberg K; Åslund S; Skogevall M; Andersson P
    Int J Pharm; 2016 May; 504(1-2):27-38. PubMed ID: 26965200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid formulation screening with a Multipart Microscale Fluid bed Powder processor.
    Kivikero N; Murtomaa M; Antikainen O; Hatara J; Juppo AM; Sandler N
    Pharm Dev Technol; 2011 Aug; 16(4):358-66. PubMed ID: 20387990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C; Price R; Shur J; Kaerger JS; Edge S
    Int J Pharm; 2010 May; 390(2):134-41. PubMed ID: 20100552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
    Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the effects of high shear blending on lactose and drug using fluidised bed elutriation.
    Willetts JP; Robbins PT; Roche TC; Bowley M; Bridson RH
    Int J Pharm; 2012 Sep; 434(1-2):272-9. PubMed ID: 22683647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S; Faulhammer E; Calzolari V; Biserni S; Dreu R; Šibanc R; Paudel A; Khinast JG
    Int J Pharm; 2017 Jan; 516(1-2):9-20. PubMed ID: 27826028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a fluid bed granulation design space using critical quality attribute weighted tolerance intervals.
    Zacour BM; Drennen JK; Anderson CA
    J Pharm Sci; 2012 Aug; 101(8):2917-29. PubMed ID: 22570275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlations between micromeritic properties of mixing powders of danshen extract and formability of their pellets].
    Xtong ZW; Luo Y; Liao ZG; Zhao GW; Li Z; Luo J
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4317-23. PubMed ID: 25850259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporating Turbula mixers into a blending scale-up model for evaluating the effect of magnesium stearate on tablet tensile strength and bulk specific volume.
    Kushner J
    Int J Pharm; 2012 Jun; 429(1-2):1-11. PubMed ID: 22405966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blend uniformity end-point determination using near-infrared spectroscopy and multivariate calibration.
    Sulub Y; Konigsberger M; Cheney J
    J Pharm Biomed Anal; 2011 Jun; 55(3):429-34. PubMed ID: 21398064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
    Capece M; Huang Z; Davé R
    J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the origins of content non-uniformity in high-shear wet granulation.
    Oka S; Smrčka D; Kataria A; Emady H; Muzzio F; Štěpánek F; Ramachandran R
    Int J Pharm; 2017 Aug; 528(1-2):578-585. PubMed ID: 28627457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.